Theravance Bio Ord (TBPH)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 174,773 | 281,927 | 110,614 | 37,797 | 23,378 |
| Marketable Securities | 154,907 | 56,877 | 20,241 | 50,553 | 67,983 |
| Receivables | 18,267 | 21,919 | 15,353 | 68,440 | 16,845 |
| Other current assets | 0 | 0 | 0 | 0 | 597 |
| TOTAL | $354,697 | $366,294 | $150,264 | $161,067 | $116,480 |
| Non-Current Assets | |||||
| PPE Net | 6,257 | 6,641 | 7,028 | 7,418 | 7,788 |
| Investments And Advances | 3,029 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 51,477 | 53,100 | 186,290 | 185,676 | 231,837 |
| TOTAL | $60,763 | $59,741 | $193,318 | $193,094 | $239,625 |
| Total Assets | $415,460 | $426,035 | $343,582 | $354,161 | $356,105 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 2,213 | 1,675 | 2,408 | 2,242 | 1,454 |
| Accrued Expenses | 13,029 | 9,718 | 7,906 | 10,006 | 9,221 |
| Other current liabilities | N/A | N/A | N/A | N/A | 6,490 |
| TOTAL | $37,407 | $54,633 | $31,502 | $32,085 | $23,435 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 145,372 | 146,554 | 146,097 | 146,531 | 147,016 |
| TOTAL | $145,372 | $146,554 | $146,097 | $146,531 | $147,016 |
| Total Liabilities | $182,779 | $201,187 | $177,599 | $178,616 | $170,451 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 50,672 | 50,361 | 50,001 | 49,471 | 49,174 |
| Common Shares | 1 | 1 | 1 | N/A | N/A |
| Retained earnings | -920,651 | -924,266 | -979,101 | -965,522 | -949,995 |
| Other shareholders' equity | 32 | -10 | 0 | 7 | 50 |
| TOTAL | $232,681 | $224,848 | $165,983 | $175,545 | $185,654 |
| Total Liabilities And Equity | $415,460 | $426,035 | $343,582 | $354,161 | $356,105 |